SC 13G Filing

Company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Filed

October 13, 2020

Accession Number

0001076809-20-000178

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →